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e-mail address: i_melaroud@hotmail.com (I. Elaraoud).Ibrahim Elaraoud ⇑; Hanif J. Suleman; Peter Cikatricis; Helen PalmerAbstractA 69-year-old man became aware of people’s speech being out of synch with their lip movements alongside persistent headaches,
both of which progressively worsened. A few weeks later, he developed progressive and painless visual loss in one eye. Initial neu-
rological evaluation, inflammatory markers and head computed tomography scan were normal. Ophthalmological examination
and OCT scan revealed right macular subretinal fluid with choroidal indentation, which prompted urgent further investigations
including head MRI revealing extensive leptomeningeal disease. The patient continued to deteriorate and deceased shortly
afterwards.
This is the first reported case of neoplastic leptomeningeal disease presenting with loss of vision due to choroidal metastasis with
localised exudative retinal detachment. Diagnosing neoplastic leptomeningeal disease requires a high index of suspicion from the
treating physician. Symptoms may be nonspecific and/or subtle. Combining cerebrospinal fluid cytology from lumbar puncture
with contrast-enhanced magnetic resonance imaging of the brain is considered the optimal diagnostic approach.
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Leptomeningeal metastases are a late complication cancer
that result from dissemination of malignant cells into cere-
brospinal fluid (CSF), arachnoid mater, pia mater and sub-
arachnoid space. It is estimated to occur in 5% of patients
with malignancies but is likely to become more frequent as
survival from systemic disease increases and many novel can-
cer drugs fail to achieve therapeutic concentrations in the
central nervous system.1
The clinical manifestations of neoplastic leptomeningeal
disease (NLMD) can be highly variable and may affect bothcentral and peripheral nervous systems, making diagnosis dif-
ficult. The diagnosis of CSF metastases is often delayed and
not appreciated until fixed neurological deficits become
evident. Ocular symptoms may represent the initial
manifestation of meningeal carcinomatosis, even in the
absence of other clinical symptoms.
In this paper we would like to share a rare case of NLMD
that initially presented with a classical optical coherence
tomography (OCT) picture of central serous chorioretinopa-
thy and evolved within a matter of weeks into an obvious
choroidal mass. We would like to raise awareness of this
devastating and fatal condition.e:
al.com
y, MRI,
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A 69-year-old male presented to his local optometrist
complaining of headache and people’s speech being out of
synchronicity with the movement of their lips for the past
1 week. His medical history was unremarkable.
The optometrist recorded a Snellen best corrected visual
acuities (BCVA) of 6/6 in each eye and an unremarkable fun-
dal examination. A diagnosis of migraine was given with sim-
ple reassurance and the patient was discharged. Six days
later he revisited the same optometrist with persisting symp-
toms and increasingly blurred vision in the right eye. BCVA
had fallen to 6/15 in the right eye and repeat fundal examina-
tion revealed a dull foveal reflex. The patient was therefore
referred to the local eye department.
Ophthalmological assessment showed no abnormalities in
the anterior segments of either eye. Dilated fundus examina-
tion revealed right macular subretinal fluid confirmed by OCT
scan. As there were no obvious retinal pigment epithelial
changes, no intraretinal fluid and no pigment epithelial
detachment, a diagnosis of presumed central serous
retinopathy (CSR) was made and explained to the patient.
Further clinical review in 2 weeks was planned.
One week later, the patient’s headache continued to wor-
sen prompting emergency admission at a different medical
centre. Neurological evaluation did not reveal any obvious
focal deficits, inflammatory markers were within normal limits
and a computed tomography (CT) of the head was reported
as normal with no evidence of space-occupying lesionsFigure 1. Right eye OCT shows subretinal fluid and choroidal indentation
(day 14).
Figure 2. (a) Axial CT scan with no obvious pathology. (b) Axial gadolinium-en
typical of NLMD.(Fig. 2a). The neurological team made a tentative diagnosis
of severe migraine and sought an ophthalmic review prior
to discharge.
On presentation to the eye clinic, the patient’s main ocular
complaint was blurred vision in the right eye and he contin-
ued to complain of audible speech being out of synchronisa-
tion with lip movements. Examination showed BCVA of 6/36
(right eye) and 6/6 (left eye), anterior segment examination
was unremarkable with no relative afferent pupillary defect
and dilated fundus examination showed right localised mac-
ular serous detachment with no signs of optic neuropathy or
papilloedema. OCT scan showed right macular subretinal
fluid with choroidal indentation (Fig. 1).
The clinical findings together with the patient’s symptoms
were suggestive of choroidal malignancy. An urgent magnetic
resonance imaging (MRI) of the brain with contrast was per-
formed, providing radiological evidence of leptomeningeal
disease (LMD) (Fig. 2b). Subsequently, a full-body staging
CT scan showed a liver mass and pleural effusion
(Fig. 3a and b). Histology of pleural paracentesis confirmed
poorly differentiated malignant cells. Unfortunately, the
patient continued to deteriorate and sadly deceased 36 h
following presentation to our emergency department.Discussion
Neoplastic leptomeningeal disease is a devastating
condition due to dissemination of malignant cells into the
CSF, leptomeninges and subarachnoid space. Although
NLMD can present as a primary tumour, it is often secondary
to a primary tumour elsewhere; most commonly breast carci-
noma, lung carcinoma and melanoma.2
Neoplastic leptomeningeal disease has a wide variety of
clinical presentations with symptoms potentially affecting
both central and peripheral nervous systems. After head-
ache, double vision is the second most frequent presenting
symptom. Other common ocular complaints include painless
loss of vision, which can either be acute or progressive over
weeks, and papilloedema, which is often present (albeit not
in this case).3 NLMD carries a very poor prognosis with
median survival rate of 3 weeks if left untreated, and this
slightly improves to few months with systemic and intrathecalhanced MRI of the same area showing extensive meningeal enhancement
Figure 3. (a) CT scan with solitary liver lesion. (b) Bilateral pleural effusion.
206 I. Elaraoud et al.chemotherapy (3–6 months survival rate).4 It is therefore
essential that ophthalmologists are aware of this fatal
condition.
Diagnosing NLMD requires a high index of suspicion from
the treating physician. It is often missed on CT and even with
gadolinium-enhanced MRI, and specificity is only 77%.5 The
most specific diagnostic test for NLMD is CSF cytology by
lumbar puncture6; initial one has a 50% sensitivity and
increases with the number of lumbar punctures performed.7
A combination of contrast MRI and CSF cytology is probably
the optimal diagnostic approach to capture most NLMD
patients.4
Our patient had painless progressive visual loss. However,
unlike published cases where vision is reduced predominantly
due to optic nerve involvement, in this case it was due to
local choroidal metastasis with localised exudative retinal
detachment. This initially resulted in an OCT picture similar
to CSR. The patient’s other main symptom of dissociation
of images and sounds was most likely caused by NLMD
affecting the visual cortex and occipito-temporal area.8
This is the first reported case of neoplastic leptomeningeal
disease presenting with vision loss due to choroidal metasta-
sis with localised exudative retinal detachment. As ophthal-
mologists we need to be able to differentiate between
simple visual symptoms such as photopsia and floaters,
where the source is ocular and requires detailed ophthalmic
examination, and more complex visual symptoms such as
palinopsia, cerebral polyopia and akinetopsia, for which neu-
roimaging in the form of MRI is required. Therefore, any his-
tory of severe, longstanding headaches, associated visual or
auditory hallucinations should be treated with high index of
suspicion and detailed ophthalmic and medical examination
should be carried out. In this case the CT scan with negative
inflammatory markers gave false reassurance of no sinister
brain pathology, and the patient’s headaches were attributed
to migraine. Although migraine is a common neurological
complaint, one should be suspicious of persistent migraine-
like symptoms.9Competing interests
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